[The interest of 18FDG-PET in the management of testicular cancer].
The key to prognosis. Initial staging and early recurrence diagnosis are key parameters in the treatment and outcome of testicular cancer. Initial staging. It is difficult using conventional modalities, which can miss node involvement and are non-specific since enlargement does not rhyme with involvement. 18FDG PET improves the accuracy of initial staging. Residual mass and recurrences. Existence of residual mass or enhancement of its Volume in the presence of an otherwise beneficial chemotherapy is difficult to manage. Several studies have demonstrated the value of 18FDG imaging in such cases. As for follow-up whole body 18FDG can prevent multiple diagnostic imaging and can diagnose recurrences with greater diagnostic accuracy than with other imaging modalities.
Tamgac
Feyzi
F
Upres 2360, CHU Avicenne, Université Paris XIII (75). tamgac@uludag.edu.tr
Tofighi
Mojdeh
M
Baillet
Georges
G
Weinmann
Pierre
P
Moretti
Jean-Luc
JL
D000293:Adolescent; D000328:Adult; D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D011379:Prognosis; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D018239:Seminoma / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000401:mortality; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000401:mortality; D013997:Time Factors; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18